Chief of Australia’s biggest biotech retires abruptly
The leader of Australia’s largest biopharmaceutical company has retired suddenly amid concerns about the company’s growth prospects and operations.
The $89 billion company announced that Paul McKenzie is stepping down as chief executive officer and chief executive of CSL on Tuesday.
“Paul and the board decided now is the right time for new leadership to continue supporting CSL’s strategic transformation and performance,” said Chairman Brian McNamee.
Former CSL chief executive Gordon Naylor, who is a non-executive director of the company, has been appointed as interim CEO and managing director.
He begins his role on Wednesday.
Dr. McNamee, MD. He acknowledged McKenzie’s contributions and dedication to CSL over the past seven years, including three as CEO.
“During his tenure, Paul guided CSL’s global operations through the challenges of COVID-19, stabilizing production and supply chains and increasing plasma collection volumes above pre-pandemic levels,” Dr McNamee said.
CSL cut its 2025/26 earnings forecast in October due to falling vaccination rates in the US and lower demand for the blood protein albumin from China, sparking a sharp selloff in CSL shares.
Dr McNamee expressed disappointment at the company’s annual general meeting, adding that CSL’s operations had become too complex to respond decisively.
Dr McKenzie said the last three years had been challenging from a business perspective, but he was proud of organizational improvements, continued investment in research and development and the new vaccine facility in Melbourne.
Dr Gordon has a 33-year tenure at CSL, including as chief financial officer and head of the CSL Seqirus influenza vaccine division.
CSL shares closed at $183.64 on Tuesday, up 1.8 percent from Monday but are down 32.1 percent over the past 12 months.
Australia’s Associated Press is the beating heart of Australian news. AAP is Australia’s only independent national news channel and has been providing accurate, reliable and fast-paced news content to the media industry, government and corporate sector for 85 years. We inform Australia.
